Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy

被引：0
|
作者：
Philip J. Saylor
Nancy L. Keating
Matthew R. Smith
机构：
[1] Massachusetts General Hospital Cancer Center,Division of Hematology
[2] Harvard Medical School,Oncology
来源：
Journal of General Internal Medicine | 2009年 / 24卷
关键词：
prostate cancer; survivorship; GnRH agonists; osteoporosis; bisphosphonates; diabetes; obesity; cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 394
页数：5
相关论文
共 50 条
  • [21] Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer
    Agarwal, Megha
    Canan, Timothy
    Glover, Greg
    Thareja, Nidhi
    Akhondi, Andre
    Rosenberg, Joshua
    CURRENT ONCOLOGY REPORTS, 2019, 21 (10)
  • [22] ANDROGEN DEPRIVATION THERAPY AND ADVERSE CARDIOVASCULAR EVENTS IN MEN WITH PROSTATE CANCER
    Siu, Chung Wah
    Huang, Gang
    Tse, Hung-Fat
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1739 - E1739
  • [23] Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications
    Collins, Lauren
    Basaria, Shehzad
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (02) : 222 - 225
  • [24] The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review
    Edmunds, Kim
    Tuffaha, Haitham
    Scuffham, Paul
    Galvao, Daniel A.
    Newton, Robert U.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 5661 - 5671
  • [25] Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on muscle and bone health
    Bargiota, Alexandra
    Oeconomou, Athanasios
    Zachos, Ioannis
    Samarinas, Michel
    Pisters, Luis L.
    Tzortzis, Vassilios
    JOURNAL OF BUON, 2020, 25 (03): : 1286 - 1294
  • [26] The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review
    Kim Edmunds
    Haitham Tuffaha
    Paul Scuffham
    Daniel A Galvão
    Robert U Newton
    Supportive Care in Cancer, 2020, 28 : 5661 - 5671
  • [27] Toremifene - a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy
    Taneja, SS
    Smith, MR
    Dalton, JT
    Raghow, S
    Barnette, G
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (03) : 293 - 305
  • [28] Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 1 - 30
  • [29] Androgen deprivation therapy for prostate cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (10): : E567 - E567
  • [30] Androgen deprivation therapy for prostate cancer
    Sharifi, N
    Gulley, JL
    Dahut, WL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02): : 238 - 244
12345